A small wool blanket wrapped around a baby who is stillborn or lost during pregnancy can make a significant difference in an acute situation of loss. This is shown in an artistic research dissertation from the University of Gothenburg.

Three faculty researchers from The University of Texas at San Antonio were celebrated with the inaugural Texas Innovation Award, a new statewide award recognizing leadership in translating academic research into real-world impact.

A phase 2 clinical trial showed burosumab, a targeted antibody therapy, safely restored phosphate balance in children and adults with fibrous dysplasia, a rare bone disorder associated with fractures and deformities. The therapy reduced abnormal bone turnover markers and improved mobility in severely affected children, including independent walking after full-time wheelchair use. The findings suggest that inhibition of fibroblast growth factor-23 may help reduce disability and improve physical function in patients with phosphate-wasting skeletal disease.

Osteosarcoma is an aggressive bone cancer characterized by high rate of recurrence and metastasis. In a new study, researchers show that restoring the RNA-editing enzyme adenosine deaminase acting on RNA 2 (ADAR2) slows tumor growth, reduces invasion, promotes bone-like differentiation, and improves chemotherapy sensitivity in cell and mouse models. The findings identify IGFBP7 RNA editing as a key mechanism underlying these effects, highlighting a potential differentiation-based treatment strategy for pediatric patients with bone cancer.

The Universitat Jaume I of Castelló has secured nearly one million euros for five projects under the competitive call for grants aimed at strengthening research careers, within the Human Resources programme of the 2024–2027 State Plan for Scientific, Technical and Innovation Research. This achievement places the UJI fourth nationally and first in the Valencian Community in terms of funding obtained in this call, behind only the Spanish National Research Council (CSIC), the University of Barcelona and the Universitat Politècnica de Catalunya, and ahead of larger universities.

The 2025 call awarded a total of 130 grants worth almost 25 million euros. Its aim is to support the consolidation of the professional careers of national and international researchers within the Spanish System for Science, Technology and Innovation (SECTI), through the creation of permanent positions and by facilitating the launch or strengthening of research lines via funding for R&D&I projects and the improvement of laboratories, facilities and scientific equipment.